Xarelto Lawsuit Alleges Drug Caused Vermont Man’s Parenchymal Hemorrhage And Death

November 18, 2015 – – BloodThinnerHelp.com reports on details from another lawsuit filed against blood-thinning drug Xarelto and manufactureres Janssen Pharmaceuticals and Bayer AG. The suit is just one of many which similarly allege that Xarelto causes uncontrollable bleeding that can lead to severe injury or death. The suit was filed under case number 2:14-cv-00159-cr in Vermont federal court on July 25th of last year. It was filed by a daughter for her father, who had died due to a parenchymal hemorrhage which his family alleges was caused by his use of Xarelto.

Details within the lawsuit explain that the father was admitted to the hospital and diagnosed with a parenchymal hemorrhage, however, physicians were unable to get the man to stop bleeding. His blood would not clot due to the fact that there was active Xarelto in his system. Because the drug has no antidote, physicians were unable to counter its effects. The man had taken Xarelto for less than one month when he died due to his uncontrollable internal bleeding on the 1st of August, 2012.

The man’s daughter, now representing her father in the current lawsuit, is looking to gain compensation for his wrongful death. As the administrator of her father’s estate, she is seeking damages for the cost of medical and funeral fees, as well as pain and damages. She states clearly in the suit that, had she and her father known about the dangers allegedly associated with Xarelto, they would have chosen a safer alternative to treat him. She also makes note that it shows negligence and recklessness that the manufacturers moved forward with releasing the drug to the market without any corresponding antidote.

Traditional blood thinners, such as warfarin, do not have this problem. When patients who have traditional blood thinners in their system are injured and bleeding, physicians are able to treat them with vitamin K, which counteracts the effects of the medication and allows their blood to clot. Xarelto does not respond to vitamin K, or to anything for that matter. Because it has no antidote, physicians have to treat patients who are bleeding with Xarelto in their systems by resorting to life-saving measures such as blood transfusions in an attempt to keep them alive. For this reason, Xarelto is widely considered the most dangerous blood thinner currently on the market.

Xarelto has been the subject of over 2,000 lawsuits across the country. Around 1,700 of these suits are in federal court and have been consolidated to form multidistrict litigation number 2592. Additionally, there is a mass tort group of several hundred cases in Philadelphia, Pennsylvania. As lawsuits concerning the drug began to mount, the U.S. Food and Drug Administration issued several warnings regarding the product.

Attorney Marc Goldich is working to ensure that anyone who has suffered adverse health effects after using Xarelto is able to explore their full legal rights. These individuals may be entitled to compensation. Currently, Attorney Goldich is offering free consultations to those involved.

To ask questions regarding this release, or to obtain additional information on the pending Xarelto litigation, please contact Marc Goldich, Esq. at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60005579